SibleyWAFoleyJM.Measles antibodies in multiple sclerosis. Trans Am Neurol Assoc1963; 88: 277–281.
2.
SibleyWAFoleyJM.Infection and immunization in multiple sclerosis. Ann NY Acad Sci1965; 122: 457–466.
3.
SibleyWABamfordCRLagunaJF.Influenza vaccination in patients with multiple sclerosis. JAMA1976; 236: 1965–1966.
4.
BamfordCRSibleyWALagunaJF.Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol1978; 35: 242–243.
5.
SibleyWABamfordCRClarkK.Clinical viral infections and multiple sclerosis. Lancet1985; 1: 1313–1315.
6.
SchumacherGABeebeGKiblerRF. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental therapy in multiple sclerosis. Ann NY Acad Sci1965; 122: 552–568.
7.
RoseASKuzmaJWKurtzkeJF. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbations. Trans Am Neurol Assoc1969; 94: 126–133.
8.
BamfordCRSibleyWAThiesC. Trauma as an etiologic and aggravating factor in multiple sclerosis. Neurology1981; 31: 1229–1234.
